Dr. 凯瑟琳•史密斯 is a hematologist-oncologist who cares for patients with acute leukemia and myeloproliferative neoplasms (blood cancers that occur when the body overproduces one of the blood cell types). She specializes in acute myeloid leukemia (also known as acute myelogenous leukemia or AML), a cancer of the blood and bone marrow that spreads rapidly. She has a particular interest in treating AML patients who have mutations in the FLT3 gene, which is involved in leukemia cell growth, division and survival and is a factor that may be useful in making a prognosis.
史密斯's research focuses on understanding why some patients do not respond to AML therapies and on developing new strategies to treat these patients.
A San Francisco native, 史密斯 earned her medical degree from Duke University and completed a residency in internal medicine at Brigham and Women's Hospital. She then completed a fellowship in hematology and oncology at UCSF.
Duke University, 2002
Brigham and Women's Hospital, Internal Medicine, 2005
UCSF, Hematology-Oncology, 2009
Hematology, American Board of Internal Medicine
副教授
广东话
4.9